Zimmer Biomet Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on April 26, 2019, by Zimmer Biomet Holdings, Inc. The report serves to announce the Company's financial results for the quarter ended March 31, 2019. The detailed financial data is contained within a press release attached as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained in the attached press release (Exhibit 99.1) but are not explicitly stated in the body of this 8-K document.
Material Changes
The filing does not detail specific material changes versus the prior comparable period within the text provided. It directs readers to the attached press release for the full results of operations and financial condition.
Guidance, Outlook, and Risks
The document does not contain specific management commentary, guidance, outlook, or risk factors in its main text. It notes that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific revenue and earnings figures in the attached press release (Exhibit 99.1) as they are not listed in this summary document.
- Confirm the Company's status as a Delaware corporation with principal offices in Warsaw, Indiana.
- Note that the financial information in this report is furnished and not "filed" under Section 18 of the Exchange Act, limiting liability exposure for the Company regarding this specific text.
- Check the attached press release for any forward-looking statements or updated guidance not present in this 8-K.